The financing comes after the company raised $30 million in August.
Iterative Scopes will focus on inflammatory bowel disease and colorectal cancer prevention with the development of its AI technology products and services.
The company offers an automated polyp detection tool, endoscopic scoring systems and a recruitment service for pharmaceutical companies to accelerate their IBD clinical trials.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.